CS Paper Radar

A Physiology-Informed Digital Twin Framework for Simulating Liver Health Progression

Sumaiya Afroz Mila, Sandip Ray

cs.LG ·submitted 2026-08-15 01:40 UTC · v1

Abstract

We present a physiology-informed digital twin of the human liver designed for longitudinal simulation of liver function and early-stage disease progression. The model, referred to as HEPATWIN, integrates key hepatic processes, including carbohydrate, lipid, and protein metabolism, bilirubin conjugation, bile production, and detoxification, within a unified systems-level framework to generate clinically observable biomarker trajectories. Unlike purely data-driven approaches, HEPATWIN incorporates mechanistic representations of liver physiology and patient-specific inputs such as diet, activity, and baseline biomarkers to simulate disease evolution over time. To ensure consistency with clinical progression patterns, we introduce a stage-transition-driven calibration mechanism that aligns simulated outputs with population-level biomarker distributions across disease stages, including NAFLD, fibrosis, and cirrhosis. Validation using the NIDDK NAFLD dataset demonstrates that HEPATWIN produces longitudinal biomarker estimates within clinically acceptable ranges and can forecast trajectories over multi-year horizons. Furthermore, simulated biomarkers retain sufficient clinical signal to support downstream NASH detection with competitive performance relative to models using ground-truth laboratory data. These results highlight the potential of physiology-informed digital twins for personalized, non-invasive diagnosis and prediction of organ health in general and liver health monitoring in particular.

Comment
This paper is under review at IEEE Journal of Biomedical and Health Informatics (JBHI)

Closest papers

Nearest neighbours by meaning across the whole index.

LifeLong Digital Twin: A Unified Modeling Paradigm and Agent Harness for Event-Driven Lifelong Health State Trajectories

cs.AI q-bio.QM ·2026-10-04 ·Jin Jiang, Sean Yates, Jasper Chong, Raymond Brooks, Alex Lawson +2 more
similarity 0.66
Abstract · 15 pages, 5 figures, 2 tables. Technical report

Human health is a continuous, dynamic trajectory shaped by the cumulative interplay of biological processes, clinical events, behaviors and environmental exposures across the life course. Unifying the full breadth of lifelong health information, including longitudinal records, genetic variation, molecular profiles and environmental histories, is essential for whole-person modeling and remains a major challenge. We introduce LifeLong Digital Twin, a unified, event-driven modeling paradigm that organizes Life Events into daily Health States and accumulates them into Lifelong Health Context. An accompanying Agent Harness incorporates multimodal evidence beyond the language model's textual context. We evaluate four language models across 25 disease endpoints on three tasks: Disease Trajectory Forecasting, Disease Risk Ranking and Multi-horizon Disease Prediction. The approach yields marked gains over the reference condition: model-averaged F1 increases by 22.0% for disease identification in trajectory forecasting and 18.3% for five-year disease outcomes; thyroid-disease F1 reaches 0.669. The framework provides a foundation for whole-person digital twins and research on personalized lifelong disease prevention.

0.20

Intervention-Conditioned Counterfactual Human Digital Twin Generator

cs.LG q-bio.QM ·2026-10-09 ·Saeed Farzi, Sofia Michopoulou, Christopher Kipps, Rahman Attar
similarity 0.61
Abstract

Chronic diseases evolve through long, heterogeneous trajectories shaped by interacting mediators, confounders, and treatment histories. Estimating long-term patient trajectories under alternative interventions is essential for in silico clinical trial design. However, most existing models overlook irregular visit intervals and cross-mediator dependencies, both of which are crucial for reliable long-term longitudinal prediction. Moreover, these models typically focus on outcome prediction rather than generating complete patient-state trajectories. To address these challenges, we propose CHDT, an intervention-conditioned Human Digital Twin generator under standard identification assumptions for multimodal longitudinal trajectory estimation. Its main empirical advantage arises from explicit modeling of irregular visit intervals, while cross-mediator refinement provides additional gains in selected intervention-conditioned settings. Across real-world ADNI and simulator-generated ALPACA cohorts, CHDT shows improved long-horizon patient-state fidelity relative to competing baselines. Ablation results indicate that irregular-time conditioning provides the primary empirical gain, and cross-mediator refinement provides additional improvements.

0.11

Ultrasound-Based Prediction of Cirrhosis Decompensation Using Large-Scale Computer Vision Models

eess.IV cs.AIcs.CV ·2026-09-03 ·Guangyi Zhang, Peiyun Ni, Eugene Cheah, Rajat Chandra, Peng Guo +2 more
published similarity 0.58
Abstract · 6 pages, 2 figures. Accepted and presented at IEEE EMBC 2026

Decompensation represents a critical transition in the course of cirrhosis, yet clinicians have limited non-invasive tools to reliably predict its onset. In this study, we propose a novel imaging-based approach that leverages large-scale computer vision models to analyze routine abdominal ultrasound images and extract predictive features beyond those captured by traditional laboratory-based risk scores. Ultrasound is widely available, low cost, and suitable for longitudinal surveillance, making it an attractive modality for scalable risk stratification and long-term follow-up. Our framework integrates automated ultrasound data processing with modern deep learning architectures to identify patients at high risk of decompensation prior to the occurrence of clinical deterioration. This non-invasive strategy offers a practical complement to existing clinical scoring systems and may enable earlier, more proactive management of patients with compensated cirrhosis.

0.38

Towards Reliable AI-Based Histological Staining: A Systematic Study of Scaling and Uncertainty in Unpaired Generative Models

cs.CV ·2026-08-25 ·Qasim Siddiqui, Adrian Friebel, Maiju Myllys, Zaynab Hobloss, Daniela Gonzalez +2 more
benchmarkcode/data similarity 0.58
Abstract · 37th British Machine Vision Conference, November 2026, Lancaster, UK

Liver fibrosis, the principal predictor of long-term outcome in chronic liver disease, is staged from histological estimates of collagen content. Sirius Red (SR) provides the standard quantitative readout (collagen proportionate area, CPA) but is not acquired at every clinical centre and consumes tissue, time, and reagent cost beyond the routine Hematoxylin and eosin (H&E) stain. AI-based virtual staining can generate SR directly from H&E, yet systematic benchmarks of unsupervised models are scarce and their predictive uncertainty has not been quantified, even though visually plausible outputs may not faithfully reproduce the underlying tissue structure. We therefore benchmark six unsupervised image-to-image architectures (GAN-based and diffusion-based) across 54 scaling configurations on a newly released paired H&E to SR mouse liver dataset, the first open resource for this translation task. Each configuration is evaluated jointly on perceptual, distributional, and task-specific axes plus a blinded expert reader study; the best per family is then retrained as a deep ensemble, the first systematic comparison of epistemic uncertainty across unsupervised stain-to-stain architectures. Across families, perceptual quality, task-specific error, and ensemble agreement measure largely independent axes of model fitness: GAN-based methods cluster tightly on perceptual metrics yet differ substantially on task error and ensemble agreement, while the diffusion-based method (CycleDiffusion) is qualitatively different on all three. No single metric captures these differences, so reliable virtual staining requires reporting and selecting on all three jointly. The dataset, tiling pipeline, models, and evaluation code are released publicly.

0.24

COMBIO: Automated Discovery of a Compact Composite Biomarker from Routine Laboratory Panels

cs.LG ·2026-11-06 ·Tomer D. Meirman, Lior S. Rokach, Bracha Shapira, Seffi Cohen, Noa Dagan
similarity 0.57
Abstract · 27 pages including supplementary material; 4 figures

Machine-learning models based on routine laboratory panels can predict outcomes but can be difficult to interpret and operationalize. We present COMBIO, an automated pipeline that distils such a model into a compact closed-form biomarker. The composite is a product of laboratory measurements raised to integer powers from minus two to two. The sign of each exponent indicates whether higher values of the corresponding measurement increase or decrease the composite. Shapley additive explanation values from the gradient-boosted reference model rank five candidate measurements and guide eligible exponent signs. An exhaustive search over small integer exponents selects the formula on an inner validation set, before evaluation on the reserved test set. We evaluated COMBIO across six tasks: three National Health and Nutrition Examination Survey outcomes, liver-disease classification in the Indian Liver Patient Dataset, and Medical Information Mart for Intensive Care IV in-hospital mortality and sepsis case-finding, with external evaluation in the eICU Collaborative Research Database for the two hospital tasks. Across the six test sets, COMBIO's area under the receiver operating characteristic curve differed by at most 0.03 from logistic regression using the five candidate laboratory measurements. The hospital mortality composite had an area under the curve of 0.698 in the external database. A version restricted to widely available measurements in the source hospital database achieved an area under the curve of 0.786 in a cohort covering 92% of admissions. The multiplicative representation provides compactness rather than additional accuracy, and local validation and recalibration are required before clinical use.

0.29

KMGen: A Skill-based Approach for Synthetic Individual Patient Data Generation

cs.LG ·2026-08-23 ·Jalen Jiang, Chufan Gao, Ethan Rasmussen, Stephen Z. Xie, Jimeng Sun
top venuebenchmarkcode/data similarity 0.56
Abstract

Individual patient data (IPD) from clinical trials is the substrate for survival modeling, meta-analysis, and safety research, yet IPD is rarely released. Prior work has addressed only half of this gap: reconstructing Kaplan-Meier (KM) curves from published plots -- typically requiring manual digitization or human-in-the-loop correction -- while offering no mechanism for generating the adverse-event (AE) streams that constitute the other half of a patient record. We introduce KMGen, the first end-to-end framework that (i) fully automates KM curve extraction at accuracy competitive with human-guided tools, and (ii) generates synthetic per-patient AE trajectories from public trial registry records. The extraction stage is a fully automated agentic pipeline -- an agent generates code to extract each step in the KM curve -- achieving a mean Integrated Absolute Error (IAE) of 0.0151 on a 32-plot benchmark spanning clean, edge-case, and adversarial conditions. The IPD generation stage decouples patient archetype extraction from statistical sampling: an LLM distills the trial record into arm-specific statistics, adverse events, patient demographics, and risk multipliers. A mechanistic sampler generates patient events via clinical archetypes, bootstrap rank-correlation coupling to the empirical KM curve (preserving the marginal survival distribution exactly), and cycle-based AE scheduling with an induction/maintenance split. Across three held-out oncology trials spanning an order of magnitude in cohort size and 30 independent regenerations per trial, KMGen achieves mean integrated KM absolute difference $Δ_{\text{KM}}\,{\leq}\,0.051$, sex/ECOG JSD ${\leq}\,0.013$ on 5 of 6 demographic slots, and recovers ${\geq}\,71\%$ of the top-15 AEs by exact MedDRA term under a single fixed parameter set. The pipeline is released as open source at https://github.com/chufangao/kmgen.

0.62

An Agentic AI Workflow for Liver Lesion Segmentation and Structured Radiology Reporting

cs.CV cs.LG ·2026-10-25 ·Fatma Ahmed Mansour, Rahatara Ferdousi, Zyad Medhat Mahmoud Ashor, Manar Fathy Elshenawy, Ibrahim Shehaby +2 more
similarity 0.56
Abstract

Despite advances in automated liver lesion segmentation, a gap remains between image-derived predictions and clinically interpretable radiology reports. Bridging this gap requires quantitative measurements that are both reproducible and traceable. We present an evidence-grounded agentic AI framework that connects liver and lesion segmentation with deterministic quantification and structured reporting. TotalSegmentator-based nnU-Net models delineate the liver, Couinaud segments, and lesions, while computational tools extract volumes, dimensions, counts, and anatomical locations. A large language model (LLM) organizes these measurements into a predefined reporting schema, with numerical consistency checks against source measurements. On 51 LiTS cases, the segmentation stage achieved a liver Dice score of 0.947, lesion sensitivity of 75.6%, and positive predictive value of 68.9%. Exploratory screening of 25,494 MERLIN reports identified 10,208 (40.0%) with liver-related abnormalities. By connecting quantitative imaging evidence with agentic report generation, this work takes a step toward human-centered medical AI that prioritizes traceability and clinical relevance.

0.23

APOD: reasoning-guided agentic population ordinary differential equation discovery for pharmacological digital twins

cs.AI q-bio.QMcs.LGstat.AP ·2026-10-05 ·Romain Ferrara, Martin Soucail, Victor Gertner, Adil Moussali, Joris Cocquebert +5 more
similarity 0.56
Abstract

Establishing ordinary differential equations (ODEs) describing population data is a fundamental part of mathematical modeling in pharmacology, crucial to developing digital twins. However, doing so from sparse, noisy data is a slow, expert-driven task. Existing automated methods either search a restricted model space or ignore population inter-individual variability. Here we introduce APOD (Agentic Population ODE Discovery), a language-model agent that iteratively reasons over biological knowledge and fit diagnostics in an open-ended search space to discover a population digital twin (PDT), i.e., a shared ODE system with between-subject variability. On synthetic pharmacokinetic and tumor-dynamics benchmarks, APOD recovered ground-truth structures in 94-100\% of runs, 12-fold faster in median than an established library-based search. On real cohorts it converged to valid structures, and proposed a PDT of radioligand-therapy-induced platelet dynamics that predicts thrombocytopenia from first-cycle data and simulates alternative dosing schedules that lower the predicted risk of toxicity.

0.29